The estimated Net Worth of Rafael Tordjman is at least $19.3 Millón dollars as of 18 February 2014. Rafael Tordjman owns over 230,769 units of Flexion Therapeutics Inc stock worth over $19,349,462 and over the last 11 years Rafael sold FLXN stock worth over $0.
Rafael has made over 1 trades of the Flexion Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Rafael bought 230,769 units of FLXN stock worth $2,999,997 on 18 February 2014.
The largest trade Rafael's ever made was buying 230,769 units of Flexion Therapeutics Inc stock on 18 February 2014 worth over $2,999,997. On average, Rafael trades about 115,385 units every 0 days since 2014. As of 18 February 2014 Rafael still owns at least 2,105,491 units of Flexion Therapeutics Inc stock.
You can see the complete history of Rafael Tordjman stock trades at the bottom of the page.
Rafael's mailing address filed with the SEC is C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON, MA, 01803.
Over the last 11 years, insiders at Flexion Therapeutics Inc have traded over $7,066,621 worth of Flexion Therapeutics Inc stock and bought 7,091,809 units worth $98,920,816 . The most active insiders traders include Holdings A/S Novo, Bradley J Ph D Bolzon y Samuel D Colella. On average, Flexion Therapeutics Inc executives and independent directors trade stock every 24 days with the average trade being worth of $609,564. The most recent stock trade was executed by Christina Willwerth on 19 July 2021, trading 3,945 units of FLXN stock currently worth $25,445.
Flexion Therapeutics is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun.
Flexion Therapeutics Inc executives and other stock owners filed with the SEC include: